Journal of The National Medical Association · 2006 · 10 citations · 0 references
MedicinePharmacokineticsPharmacologyClinical PharmacologyPharmacogeneticsPharmacogenomicsCytochrome P450 InteractionsCytochrome P450-mediated MetabolismDrug DispositionCyp2c19 Drug MetabolismCyp2c19 GenotypeCyp2c19 PharmacogeneticsCyp450-mediated InteractionsMetabolic Clearance ChangesMetabolic Clearance Rate
Taken together, the results indicate that CYP2C9 is the major contributor to Gz metabolic clearance, although CYP2C19 may also be involved in MeOH-Gz formation (the major metabolic pathway). Factors known to influence CYP2C9 activity will provide the main source of variability in Gz pharmacokinetics.